SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

13 May 2026 Evaluate
Revenue showed a marginal decline at Rs. 0.93 millions. For the quarter ended March 2026, as compared to corresponding quarter of last year.The Total Profit for the quarter ended March 2026 of Rs. 0.34 millions grew from Rs.-0.67 millionsThe company reported a degrowth in operating Profit to 1.05 millions from 2.85 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 0.93 0.96 -3.12 3.71 6.11 -39.28 3.71 6.11 -39.28
Other Income 4.73 6.08 -22.20 20.36 20.09 1.34 20.36 20.09 1.34
PBIDT 1.05 2.85 -63.16 6.83 10.58 -35.44 6.83 10.58 -35.44
Interest 0.01 0.01 0.00 0.02 0.01 100.00 0.02 0.01 100.00
PBDT 1.04 2.84 -63.38 6.81 10.57 -35.57 6.81 10.57 -35.57
Depreciation 0.25 0.24 4.17 1.00 0.98 2.04 1.00 0.98 2.04
PBT 0.79 2.60 -69.62 5.81 9.59 -39.42 5.81 9.59 -39.42
TAX 0.45 3.27 -86.24 1.44 6.42 -77.57 1.44 6.42 -77.57
Deferred Tax -0.08 -0.08 0.00 -0.37 2.02 -118.32 -0.37 2.02 -118.32
PAT 0.34 -0.67 -150.75 4.37 3.17 37.85 4.37 3.17 37.85
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 112.90 296.88 -61.97 184.10 173.16 6.32 184.10 173.16 6.32

Emmessar Biotech&Nut Share Price

24.75 0.14 (0.57%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: